Patents by Inventor Ajit K. Verma

Ajit K. Verma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150031697
    Abstract: Provided herein are methods of preventing skin cancer, where the methods comprise the step of administering an effective amount of at least one Hsp90 inhibitor to a subject at the risk of developing skin cancer, whereby the skin cancer is prevented in the subject.
    Type: Application
    Filed: July 25, 2014
    Publication date: January 29, 2015
    Inventor: Ajit K. Verma
  • Patent number: 6897352
    Abstract: Non-human mammalian animals having a higher epidermal expression level of protein kinase C? than their wild-type counterparts are phenotypically distinguished from wild-type animals in that the animals induced to develop tumors in a chemical initiation/promotion protocol are suppressed for subsequent papilloma development but are susceptible to developing squamous cell carcinoma and metastatic squamous cell carcinoma. The animals are advantageously used in methods for screening putative agents for altering the susceptibility, development and progression of squamous cell carcinoma and metastatic squamous cell carcinoma and have further commercial value as tools for investigating the development of metastatic disease.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: May 24, 2005
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ajit K. Verma, Deric L. Wheeler
  • Publication number: 20030051258
    Abstract: Non-human mammalian animals having a higher epidermal expression level of protein kinase C&egr; than their wild-type counterparts are phenotypically distinguished from wild-type animals in that the animals induced to develop tumors in a chemical initiation/promotion protocol are suppressed for subsequent papilloma development but are susceptible to developing squamous cell carcinoma and metastatic squamous cell carcinoma. The animals are advantageously used in methods for screening putative agents for altering the susceptibility, development and progression of squamous cell carcinoma and metastatic squamous cell carcinoma and have further commercial value as tools for investigating the development of metastatic disease.
    Type: Application
    Filed: August 27, 2002
    Publication date: March 13, 2003
    Inventors: Ajit K. Verma, Deric L. Wheeler
  • Patent number: 6521815
    Abstract: Non-human mammalian animals having a higher epidermal expression level of protein kinase C&egr; than their wild-type counterparts are phenotypically distinguished from wild-type animals in that the animals induced to develop tumors in a chemical initiation/promotion protocol are suppressed for subsequent papilloma development but are susceptible to developing squamous cell carcinoma and metastatic squamous cell carcinoma. The animals are advantageously used in methods for screening putative agents for altering the susceptibility, development and progression of squamous cell carcinoma and metastatic squamous cell carcinoma and have further commercial value as tools for investigating the development of metastatic disease.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: February 18, 2003
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Ajit K. Verma, Peter J. Reddig, Aaron P. Jansen